ARTICLE | Clinical News
Avastin bevacizumab: Phase III data
June 7, 2004 7:00 AM UTC
Previously reported results from a Phase III trial in 813 patients showed that those given irinotecan, bolus fluorouracil and leucovorin (IFL) plus Avastin survived significantly longer than those giv...